PUREfi Wealth LLC Purchases New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

PUREfi Wealth LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 997 shares of the healthcare conglomerate’s stock, valued at approximately $504,000.

A number of other large investors also recently bought and sold shares of the company. PICTET BANK & TRUST Ltd raised its position in UnitedHealth Group by 4.1% during the 4th quarter. PICTET BANK & TRUST Ltd now owns 3,300 shares of the healthcare conglomerate’s stock worth $1,669,000 after buying an additional 130 shares during the last quarter. Bank Pictet & Cie Europe AG raised its position in UnitedHealth Group by 3.9% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after buying an additional 9,872 shares during the last quarter. Chevy Chase Trust Holdings LLC grew its stake in shares of UnitedHealth Group by 4.3% during the 4th quarter. Chevy Chase Trust Holdings LLC now owns 697,335 shares of the healthcare conglomerate’s stock worth $352,754,000 after purchasing an additional 28,940 shares during the period. Campbell Wealth Management grew its stake in shares of UnitedHealth Group by 27.7% during the 4th quarter. Campbell Wealth Management now owns 502 shares of the healthcare conglomerate’s stock worth $254,000 after purchasing an additional 109 shares during the period. Finally, Asset Planning Inc acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $1,058,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Down 1.4 %

NYSE UNH opened at $523.48 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company’s 50 day moving average price is $523.63 and its 200 day moving average price is $563.48. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $481.75 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on UNH. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.